Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis
- 1 August 2000
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 140 (2) , 206-211
- https://doi.org/10.1067/mhj.2000.107554
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Acute profound thrombocytopenia after abciximab therapy during coronary angioplastyClinical Cardiology, 1998
- Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary SyndromesNew England Journal of Medicine, 1998
- Occurrence and clinical significance of thrombocytopenia in a population undergoing high-risk percutaneous coronary revascularizationJournal of the American College of Cardiology, 1998
- A Comparison of Aspirin plus Tirofiban with Aspirin plus Heparin for Unstable AnginaNew England Journal of Medicine, 1998
- Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial InfarctionNew England Journal of Medicine, 1998
- Effects of Platelet Glycoprotein IIb/IIIa Blockade With Tirofiban on Adverse Cardiac Events in Patients With Unstable Angina or Acute Myocardial Infarction Undergoing Coronary AngioplastyCirculation, 1997
- Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary RevascularizationNew England Journal of Medicine, 1997
- Abciximab-associated profound thrombocytopenia: Therapy with immunoglobulin and platelet transfusionThe American Journal of Cardiology, 1996
- Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary AngioplastyNew England Journal of Medicine, 1994
- Monoclonal Antibodies to Platelet Glycoprotein IIb/IIIa as Antithrombotic AgentsaAnnals of the New York Academy of Sciences, 1991